Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

Monte L. Anderson, Tousif M. Pasha, Jonathan A Leighton

Research output: Contribution to journalArticle

553 Citations (Scopus)

Abstract

Objectives: Irritable bowel syndrome is the most common gastrointestinal diagnosis. The symptoms of irritable bowel syndrome are similar to those of small intestinal bacterial overgrowth. The purpose of this study was to test whether overgrowth is associated with irritable bowel syndrome and whether treatment of overgrowth reduces their intestinal complaints. Methods: Two hundred two subjects in a prospective database of subjects referred from the community undergoing a lactulose hydrogen breath test for assessment of overgrowth were Rome I criteria positive for irritable bowel syndrome. They were treated with open label antibiotics after positive breath test. Subjects returning for follow-up breath test to confirm eradication of overgrowth were also assessed. Subjects with inflammatory bowel disease, abdominal surgery, or subjects demonstrating rapid transit were excluded. Baseline and after treatment symptoms were rated on visual analog scales for bloating, diarrhea, abdominal pain, defecation relief, mucous, sensation of incomplete evacuation, straining, and urgency. Subjects were blinded to their breath test results until completion of the questionnaire. Results: Of 202 irritable bowel syndrome patients, 157 (78%) had overgrowth. Of these, 47 had follow-up testing. Twenty-five of 47 follow-up subjects had eradication of small intestinal bacterial overgrowth. Comparison of those that eradicated to those that failed to eradicate revealed an improvement in irritable bowel syndrome symptoms with diarrhea and abdominal pain being statistically, significant after Bonferroni correction (p < 0.05). Furthermore, 48% of eradicated subjects no longer met Rome criteria (χ2 = 12.0, p < 0.001). No difference was seen if eradication was not successful. Conclusions: Small intestinal bacterial overgrowth is associated with irritable bowel syndrome. Eradication of the overgrowth eliminates irritable bowel syndrome by study criteria in 48% of subjects. (C) 2000 by Am. Coll. of Gastroenterology.

Original languageEnglish (US)
Pages (from-to)3503-3506
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume95
Issue number12
DOIs
StatePublished - 2000

Fingerprint

Irritable Bowel Syndrome
Breath Tests
Abdominal Pain
Diarrhea
Lactulose
Defecation
Gastroenterology
Visual Analog Scale
Inflammatory Bowel Diseases
Hydrogen
Databases
Anti-Bacterial Agents
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. / Anderson, Monte L.; Pasha, Tousif M.; Leighton, Jonathan A.

In: American Journal of Gastroenterology, Vol. 95, No. 12, 2000, p. 3503-3506.

Research output: Contribution to journalArticle

@article{fae47421840d4494b91d81fbd4d7bb2a,
title = "Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome",
abstract = "Objectives: Irritable bowel syndrome is the most common gastrointestinal diagnosis. The symptoms of irritable bowel syndrome are similar to those of small intestinal bacterial overgrowth. The purpose of this study was to test whether overgrowth is associated with irritable bowel syndrome and whether treatment of overgrowth reduces their intestinal complaints. Methods: Two hundred two subjects in a prospective database of subjects referred from the community undergoing a lactulose hydrogen breath test for assessment of overgrowth were Rome I criteria positive for irritable bowel syndrome. They were treated with open label antibiotics after positive breath test. Subjects returning for follow-up breath test to confirm eradication of overgrowth were also assessed. Subjects with inflammatory bowel disease, abdominal surgery, or subjects demonstrating rapid transit were excluded. Baseline and after treatment symptoms were rated on visual analog scales for bloating, diarrhea, abdominal pain, defecation relief, mucous, sensation of incomplete evacuation, straining, and urgency. Subjects were blinded to their breath test results until completion of the questionnaire. Results: Of 202 irritable bowel syndrome patients, 157 (78{\%}) had overgrowth. Of these, 47 had follow-up testing. Twenty-five of 47 follow-up subjects had eradication of small intestinal bacterial overgrowth. Comparison of those that eradicated to those that failed to eradicate revealed an improvement in irritable bowel syndrome symptoms with diarrhea and abdominal pain being statistically, significant after Bonferroni correction (p < 0.05). Furthermore, 48{\%} of eradicated subjects no longer met Rome criteria (χ2 = 12.0, p < 0.001). No difference was seen if eradication was not successful. Conclusions: Small intestinal bacterial overgrowth is associated with irritable bowel syndrome. Eradication of the overgrowth eliminates irritable bowel syndrome by study criteria in 48{\%} of subjects. (C) 2000 by Am. Coll. of Gastroenterology.",
author = "Anderson, {Monte L.} and Pasha, {Tousif M.} and Leighton, {Jonathan A}",
year = "2000",
doi = "10.1016/S0002-9270(00)02161-4",
language = "English (US)",
volume = "95",
pages = "3503--3506",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

AU - Anderson, Monte L.

AU - Pasha, Tousif M.

AU - Leighton, Jonathan A

PY - 2000

Y1 - 2000

N2 - Objectives: Irritable bowel syndrome is the most common gastrointestinal diagnosis. The symptoms of irritable bowel syndrome are similar to those of small intestinal bacterial overgrowth. The purpose of this study was to test whether overgrowth is associated with irritable bowel syndrome and whether treatment of overgrowth reduces their intestinal complaints. Methods: Two hundred two subjects in a prospective database of subjects referred from the community undergoing a lactulose hydrogen breath test for assessment of overgrowth were Rome I criteria positive for irritable bowel syndrome. They were treated with open label antibiotics after positive breath test. Subjects returning for follow-up breath test to confirm eradication of overgrowth were also assessed. Subjects with inflammatory bowel disease, abdominal surgery, or subjects demonstrating rapid transit were excluded. Baseline and after treatment symptoms were rated on visual analog scales for bloating, diarrhea, abdominal pain, defecation relief, mucous, sensation of incomplete evacuation, straining, and urgency. Subjects were blinded to their breath test results until completion of the questionnaire. Results: Of 202 irritable bowel syndrome patients, 157 (78%) had overgrowth. Of these, 47 had follow-up testing. Twenty-five of 47 follow-up subjects had eradication of small intestinal bacterial overgrowth. Comparison of those that eradicated to those that failed to eradicate revealed an improvement in irritable bowel syndrome symptoms with diarrhea and abdominal pain being statistically, significant after Bonferroni correction (p < 0.05). Furthermore, 48% of eradicated subjects no longer met Rome criteria (χ2 = 12.0, p < 0.001). No difference was seen if eradication was not successful. Conclusions: Small intestinal bacterial overgrowth is associated with irritable bowel syndrome. Eradication of the overgrowth eliminates irritable bowel syndrome by study criteria in 48% of subjects. (C) 2000 by Am. Coll. of Gastroenterology.

AB - Objectives: Irritable bowel syndrome is the most common gastrointestinal diagnosis. The symptoms of irritable bowel syndrome are similar to those of small intestinal bacterial overgrowth. The purpose of this study was to test whether overgrowth is associated with irritable bowel syndrome and whether treatment of overgrowth reduces their intestinal complaints. Methods: Two hundred two subjects in a prospective database of subjects referred from the community undergoing a lactulose hydrogen breath test for assessment of overgrowth were Rome I criteria positive for irritable bowel syndrome. They were treated with open label antibiotics after positive breath test. Subjects returning for follow-up breath test to confirm eradication of overgrowth were also assessed. Subjects with inflammatory bowel disease, abdominal surgery, or subjects demonstrating rapid transit were excluded. Baseline and after treatment symptoms were rated on visual analog scales for bloating, diarrhea, abdominal pain, defecation relief, mucous, sensation of incomplete evacuation, straining, and urgency. Subjects were blinded to their breath test results until completion of the questionnaire. Results: Of 202 irritable bowel syndrome patients, 157 (78%) had overgrowth. Of these, 47 had follow-up testing. Twenty-five of 47 follow-up subjects had eradication of small intestinal bacterial overgrowth. Comparison of those that eradicated to those that failed to eradicate revealed an improvement in irritable bowel syndrome symptoms with diarrhea and abdominal pain being statistically, significant after Bonferroni correction (p < 0.05). Furthermore, 48% of eradicated subjects no longer met Rome criteria (χ2 = 12.0, p < 0.001). No difference was seen if eradication was not successful. Conclusions: Small intestinal bacterial overgrowth is associated with irritable bowel syndrome. Eradication of the overgrowth eliminates irritable bowel syndrome by study criteria in 48% of subjects. (C) 2000 by Am. Coll. of Gastroenterology.

UR - http://www.scopus.com/inward/record.url?scp=0033636668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033636668&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(00)02161-4

DO - 10.1016/S0002-9270(00)02161-4

M3 - Article

C2 - 11151884

AN - SCOPUS:0033636668

VL - 95

SP - 3503

EP - 3506

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 12

ER -